Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

Barrett Esophagus-I: Introduction

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

Esophageal Strictures-II: Clinical Features and Management

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

Esophageal Strictures-I: Introduction

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...

Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Perioperative Safety and Effectiveness of Laparoscopic Heller Myotomy in Elderly Patients: Systematic Review and Meta-Analysis.

Surgical laparoscopy, endoscopy & percutaneous techniques·2026

Same author

European surgical residency training: a scoping review of operative exposure, assessment, wellbeing, and practice readiness.

Updates in surgery·2026

Same author

What Is the Significance of Surgeons Possessing a Thorough Understanding of Esophageal Function Tests?

The American surgeon·2026

Same author

In memoriam: Professor Alberto Montori (1933-2021)-a visionary pioneer of digestive endoscopy and surgical innovation.

Surgical endoscopy·2026

Same author

A Window on the Public's Perception of Internationally Trained Surgeons.

JAMA surgery·2026

Same author

Long-term (>10 Years) Outcomes of Laparoscopic Nissen Fundoplication: A Systematic Review and Meta-Analysis.

Annals of surgery·2025

Search research articles

Related Experiment Video

Updated: Apr 30, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Antireflux surgery for dysplastic Barrett.

Marco E Allaix¹, Marco G Patti

¹Department of Surgical Sciences, University of Torino, Torino, Italy.

World Journal of Surgery

|May 9, 2014

Summary

Antireflux surgery may help regress dysplasia in short-segment Barrett's esophagus (BE) but does not eliminate cancer risk. Long-term monitoring is crucial for patients with dysplastic BE undergoing surgery.

Area of Science:

Gastroenterology
Surgical Oncology
Esophageal Diseases

Background:

Barrett's esophagus (BE) arises from chronic esophageal injury due to gastric reflux.
BE can progress to low-grade dysplasia (LGD), high-grade dysplasia (HGD), and adenocarcinoma.
The effect of antireflux surgery (ARS) on dysplasia progression/regression in BE is debated.

Purpose of the Study:

To review the impact of ARS on the regression and progression of dysplasia in patients with BE.
To evaluate the effects of fundoplication on dysplastic Barrett's esophagus.

Main Methods:

Literature review of PubMed/Medline databases.
Analysis of studies on antireflux surgery in Barrett's esophagus patients.

Main Results:

More Related Videos

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Published on: February 16, 2024

Surgical Models of Gastroesophageal Reflux with Mice

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

Related Experiment Videos

Last Updated: Apr 30, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Published on: February 16, 2024

Surgical Models of Gastroesophageal Reflux with Mice

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

ARS may reduce, but not eliminate, the risk of dysplasia or cancer progression in BE.
ARS might promote regression of dysplastic BE in short-segment cases, but not long-segment.
Gene expression modulation is implicated in the development and reversal of short-segment intestinal metaplasia post-ARS.

Conclusions:

Long-term surveillance (24-hour pH monitoring, endoscopy) is recommended post-ARS for BE patients.
Postoperative monitoring aims to detect pathological reflux, dysplasia, or adenocarcinoma early.
Further research is needed on the molecular effects of ARS in dysplastic BE.